In a pivotal move shaping the future of MedTech, Tyber Medical, Intech, and Resolve Surgical Technologies have merged into a unified, leading developer, designer and manufacturer of surgical devices focused on serving the needs of MedTech OEMs and patients. The new group combines world-class implant and instrumentation platforms with development and regulatory expertise to offer faster, smarter solutions for OEMs worldwide, setting a new standard for innovation, speed-to-market, and strategic partnership across the industry. It is backed by a consortium of leading private investors, led by Montagu.

 A Next-Generation CDMO+ Platform 

The group unites the complementary strengths of three leading organizations into one comprehensive, innovative offering of:

• FDA-cleared and CE-marked technologies including PEEK interbodies, plates, screws, sternal closure systems, cabling, flexible reamers, handles and the SMADE IoT surgical asset tracking system
• Decades of clinical experience designing, developing, manufacturing and sustaining systems for Trauma, Extremities, Sports Medicine, Spine and Cardio-thoracic markets
• Scaled, agile operations with approximately 1,500 employees across 12 vertically integrated sites on three continents, and best-in-class equipment allowing for cost-efficient manufacturing of the highest precision and quality.
• Flexible end-to-end model supporting the full spectrum of our customers’ needs including contract manufacturing, co-development, and private labeling as a manufacturer of record – all at scale.
• Comprehensive portfolio and expertise in precision manufacturing of surgical instruments, implants and sterilization containers, enabling accelerated development processes and simplifying supply chain management for our OEM customers
• Unique regulatory capabilities including filing and sustaining 510(k), EU-MDR, CE-mark registrations for Class I, II and III surgical devices.

“This is more than a merger - it’s a shared ambition to provide solutions that shape the future of musculoskeletal care,” said Salvatore Guccione, Chairman and interim CEO of the newly formed company.

Together, the group is built to support the full continuum of medical devices product development and manufacturing, blending speed, scale, and deep specialization.

More than Manufacturing 

Intech has been pushing the boundaries of complex engineering and manufacturing challenges for over 20 years, remaining at the forefront of innovation alongside its OEM customers, including in the most stringent domains of complex instrumentation, navigation systems, and surgical robotics. 

Beyond Intech’s global contract manufacturing capabilities, the “+” in CDMO+ reflects the group’s ability to deliver end-to-end lifecycle support. Leveraging Tyber and Resolve’s integrated strength in clinical evaluation, regulatory registration, and post-market surveillance, we help OEMs accelerate product development, approval, and commercialization.

“By combining our strengths, we are supporting our OEMs with faster time-to-market, broader capabilities, and the confidence of a truly global partner.” said Jeff Tyber, founder of Tyber Medical and now President of the CDMO+ business.

With over 100 510(k)-cleared implant systems, thousands of pre-validated devices, and modular instrumentation, the group helps customers accelerate time-to-market and bring products to market efficiently through a single, trusted partner.

“This is truly unique. We now have a comprehensive portfolio and expertise in precision manufacturing of implants, surgical instruments, and sterilization containers. Combined with our unique regulatory capabilities” said Megan Osorio, CEO of Resolve.

Global Reach, Built on Trust 

With revenues of over $300m, an exclusive focus on medical devices, and consistent growth investments in its modern and scaled infrastructure, the group is ideally positioned to address its customers demand for agility, supply chain resiliency, and executional excellence.

 This global footprint not only ensures scalable capacity and technical depth - it also enables country-of-origin flexibility to help OEMs manage their sourcing strategy, trade compliance, localization, and business continuity requirements more effectively. 

“Our customers no longer need to juggle multiple vendors to achieve agility, quality, and scale.” said Laurent Pruvost, former President and CEO of Intech and now President of the CMO business. “With one integrated team and a global footprint spanning three continents, we provide the infrastructure, flexibility, and stability needed to meet today’s dynamic supply chain demands.”

As integration progresses, supply continuity remains our foremost commitment. Our integration process is designed with the needs of our customers and their patients as a priority. A phased approach ensures operational stability while identifying and scaling best practices across teams, geographies, and technologies.